Cargando…
Antibody-Positive Neuromyelitis Optica Spectrum Disorder After Second COVID-19 Vaccination: a Case Report
In the era of the COVID-19 pandemic declared in March 2020, widespread vaccination protocols were initiated to mitigate the severity and spread of COVID-19. Although COVID-19 vaccines have been generally considered safe, adverse events post-vaccination have been reported, including the development o...
Autores principales: | Kuntz, Stephanie, Saab, Georges, Schneider, Raphael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219391/ https://www.ncbi.nlm.nih.gov/pubmed/35761845 http://dx.doi.org/10.1007/s42399-022-01213-1 |
Ejemplares similares
-
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023) -
Screening for onconeural antibodies in neuromyelitis optica spectrum disorders
por: Berger, Benjamin, et al.
Publicado: (2017) -
Association of cigarette smoking with neuromyelitis optica-immunoglobulin G sero-positivity in neuromyelitis optica spectrum disorder
por: Eskandarieh, Sharareh, et al.
Publicado: (2019) -
Neuromyelitis optica spectrum disorders: An update
por: Pandit, Lekha
Publicado: (2015)